Find Information About:

Drugs & Supplements

Get information and reviews on prescription drugs, over-the-counter medications, vitamins, and supplements. Search by name or medical condition.

Pill Identifier

Pill Identifier

Having trouble identifying your pills?

Enter the shape, color, or imprint of your prescription or OTC drug. Our pill identification tool will display pictures that you can compare to your pill.

Get Started
My Medicine

My Medicine

Save your medicine, check interactions, sign up for FDA alerts, create family profiles and more.

Get Started

WebMD Health Experts and Community

Talk to health experts and other people like you in WebMD's Communities. It's a safe forum where you can create or participate in support groups and discussions about health topics that interest you.

  • Second Opinion

    Second Opinion

    Read expert perspectives on popular health topics.

  • Community


    Connect with people like you, and get expert guidance on living a healthy life.

Got a health question? Get answers provided by leading organizations, doctors, and experts.

Get Answers

Sign up to receive WebMD's award-winning content delivered to your inbox.

Sign Up

Breast Cancer Health Center

Font Size

Breast Cancer: Risk Remains Years Later

10 Years After Drug Treatment, 1 in 5 Patients Relapses

Good News for Some Patients

There was some good news in the study results for women who have breast cancers that do not rely on estrogen to grow.

These estrogen-receptor (ER) negative tumors are less common than hormone-sensitive tumors, and they are considered more deadly.

But the study showed that some women with ER-negative tumors who survived for five years after initial treatment actually had a better prognosis than women with hormone-sensitive tumors.

"These tumors are certainly more aggressive early on, but the outlook is good for women with these tumors who survive for five years," Brewster says. "We can now tell these women that their risk for developing a recurrence is lower than for women with ER-positive tumors."

American Cancer Society deputy chief medical officer Len Lichtenfeld, MD, tells WebMD that the findings highlight the benefits of treating ER-negative women with intensive chemotherapy.

"There has been some discussion about whether aggressive treatment makes a difference, and this study supports the view that it does," he says.

Lichtenfeld agrees that additional treatment options are needed for all cancer survivors, including those treated for estrogen-sensitive tumors who complete five years of hormone-targeting therapy.

"The jury is still out on what we need to be offering women who have finished five years of adjuvant treatment," he says. "What this study tells us is that these women still have a residual risk of recurrence that is significant."

1 | 2

Today on WebMD

Breast Cancer Overview
From self-exams and biopsies to reconstruction, we’ve got you covered.
Dealing with breast cancer
Get answers to your questions.
woman having mammogram
Experts don’t agree on all fronts, but you can be your own advocate.
woman undergoing breast cancer test
Many women worry. But the truth? Most abnormalities aren’t breast cancer.
Breast Cancer Treatments Improving
Resolved To Quit Smoking
Woman getting mammogram
Screening Tests for Women
ovarian cancer overview slideshow
serious woman
what is your cancer risk
10 Ways to Revitalize Slideshow